Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

ER pain study pulled before it even started

NCT ID NCT07344350

Symptom relief Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to compare an oral morphine tablet to a nasal spray painkiller (sufentanil) for treating severe acute pain in emergency departments. It planned to enroll adults with severe pain, measuring pain levels 30 minutes after treatment. However, the study was withdrawn before any participants were enrolled, so no data was collected.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Morphine sulfate (oral) and sufentanil (intranasal)
What this could lead to
If successful, it could show that a simple oral painkiller works as well as a nasal spray for severe pain in the ER.
What could go wrong
The study was withdrawn before any patients were enrolled, so no results are available. It is unclear if the approach is safe or effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients admitted to the emergency departments of Emile Muller Hospital in Mulhouse, France and Sélestat Hospital, France, with a score of 6 or higher on the numerical pain rating scale.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient presenting with severe acute pain of medical or traumatic origin at admission, with a score of 6 or higher on the numerical pain rating scale; * Aged 18 years or older; * No prior use of WHO step III analgesic before admission; * Hemodynamic, respiratory, and neurological stability; * Patient informed about the study and not opposed to participation. Non-Inclusion Criteria: * Pain related to exacerbation of chronic and/or neuropathic pain; * Sickle cell crisis; * Patient with substance abuse.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Severe acute pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Acute Pain agnosia Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Severe acute pain

Contacts and locations

Locations

  • Centre Hospitalier Sélestat

    Sélestat, Bas-Rhin, 67600, France

  • Hôpital Emile Muller

    Mulhouse, Haut-Rhin, 68100, France